HealthQuill
Generic drugs made in India, which account for 93% of such medicines made from emerging countries, are linked to hospitalisation, disability and in a few cases death, compared to the US, according to a study by the Ohio State University.
Drugs Health Research

Generic Indian drugs have a 54% higher risk compared to US

HQ Team April 18, 2025: Generic drugs made in India, which account for 93% of such medicines made from emerging countries, are linked.

Read More
Britain’s Medicines and Healthcare products Regulatory Agency has authorised GSK Plc’s combination drug to treat patients with multiple myeloma who have received at least one prior therapy.
Drugs Health Pharma

Britain gives green light for GSK Plc’s treatment of rare blood cancer

HQ Team April 18, 2025: Britain’s Medicines and Healthcare products Regulatory Agency has authorised GSK Plc’s combination drug to treat patients with multiple.

Read More
Stem cell therapies, which replace dead cells in the brain, can stop movement problems, rigidity and tremors in patients, two small trial studies show.
Drugs Health Research

Stem cell therapy revives hope for patients with Parkinson’s disease

HQ Team April 17, 2025: Stem cell therapies, which replace dead cells in the brain, can stop movement problems, rigidity and tremors in.

Read More
Escalating hostilities and limited access to medical supplies are exacerbating an already dire humanitarian crisis in Gaza depriving civilians of shelter, food and medicine, the UN warns.
Drugs Health Medical

Dire humanitarian crisis engulfs Gaza Strip, displaced people swell: UN 

HQ Team April 17, 2025: Escalating hostilities and limited access to medical supplies are exacerbating an already dire humanitarian crisis in Gaza depriving.

Read More
Sanofi S.A.’s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate of worsening episodes in adults with moderate-to-severe asthma, according to a statement.
Drugs Health Pharma

Sanofi’s test drug to treat moderate-to-severe asthma fail to meet goals 

HQ Team April 17, 2025: Sanofi S.A.’s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate.

Read More
Austria’s Cyprumed GmbH has announced a license and option agreement with Merck & Co., to develop oral formulations of the US-based company’s peptides for an upfront payment of $493 million.
Drugs Health Medical

Austria’s Cyprumed in $493 million pact with Merck to develop peptides

HQ Team April 17, 2025: Austria’s Cyprumed GmbH has announced a license and option agreement with Merck & Co., to develop oral formulations.

Read More
An oral antibiotic, gepotidacin, has shown efficacy in fighting gonorrhoea — one of the most prevalent sexually transmitted infections in the world, according to the results of an end-stage study published in The Lancet.
Drugs Health Research

Oral antibiotic shows efficacy in end-stage trials to treat gonorrhoea

HQ Team April 16, 2025: An oral antibiotic, gepotidacin, has shown efficacy in fighting gonorrhoea — one of the most prevalent sexually transmitted.

Read More
Eisai Co., Ltd. and Biogen Inc.’s drug to treat Alzheimer’s disease got marketing authorisation in the European Union, according to a joint statement from the companies.
Drugs Health Pharma

Eisai Co, Biogen Inc.’s Alzheimer’s drug gets EU’s marketing approval

HQ Team April 16, 2025: Eisai Co., Ltd. and Biogen Inc.’s drug to treat Alzheimer’s disease got marketing authorisation in the European Union,.

Read More
The 194 Member States of the WHO have reached a consensus on a draft agreement to strengthen global collaboration on prevention, preparedness and response to future pandemic threats.
Drugs Health Pharma

WHO’s Pandemic Agreement reaches consensus, may be adopted in May

HQ Team April 16, 2025: The 194 Member States of the WHO have reached a consensus on a draft agreement to strengthen global.

Read More
Using artificial intelligence Stanford researchers have developed a “digital twin” of a part of a mouse brain that processes visual information.
Drugs Health Pharma

Stanford researchers build ‘digital twin’ of a part of mouse brain

HQ Team April 15, 2025: Using artificial intelligence Stanford researchers have developed a “digital twin” of a part of a mouse brain that.

Read More